Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1022899/000149315218004567/form10-k.htm
March 2024
December 2023
November 2023
March 2023
November 2022
September 2022
June 2022
October 2021
October 2021
August 2021
Document and Entity Information - USD ($) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2017 | Mar. 30, 2018 | Jun. 30, 2017 | |
Document And Entity Information | |||
Entity Registrant Name | Protagenic Therapeutics, Inc.\new | ||
Entity Central Index Key | 0001022899 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2017 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --12-31 | ||
Entity a Well-known Seasoned Issuer | No | ||
Entity a Voluntary Filer | No | ||
Entity's Reporting Status Current | Yes | ||
Entity Filer Category | Smaller Reporting Company | ||
Entity Public Float | $ 15,230,814 | ||
Entity Common Stock, Shares Outstanding | 10,261,419 | ||
Trading Symbol | PTIX | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2017 |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1022899/000149315218004567/form10-k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Protagenic Therapeutics, Inc.New.
Protagenic Therapeutics, Inc.New's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Protagenic Therapeutics, Inc.New provided additional information to their SEC Filing as exhibits
Ticker: PTIX
CIK: 1022899
Form Type: 10-K Annual Report
Accession Number: 0001493152-18-004567
Submitted to the SEC: Mon Apr 02 2018 5:31:47 PM EST
Accepted by the SEC: Mon Apr 02 2018
Period: Sunday, December 31, 2017
Industry: Business Services